Ethambutol/isoniazid/rifampicin, also known as ethambutol/isoniazid/rifampin, is a medication used to treat tuberculosis. It is a fixed dose combination of ethambutol, isoniazid, and rifampicin. It is used either along or with other antituberculosis medication. It is taken by mouth. Side effects are those of the underlying medications. Use may not be suitable in children.
It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is about 6.74 to 16.13 USD a month.
- WHO Model Formulary 2008 (PDF). World Health Organization. 2009. p. 142. ISBN 9789241547659. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.
- "WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.
- "Rifampicin + Isoniazid + Ethambutol". International Drug Price Indicator Guide. Retrieved 8 December 2016.
|This antiinfective drug article is a stub. You can help Wikipedia by expanding it.|